4.7 Article

Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-13773-7

关键词

-

资金

  1. National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R01CA202752-01A1, R01CA208236-01A1, R21CA179327-01]
  2. National Institute of Diabetes and Digestive and Kidney Diseases [R21CA195152-01, R01DK098503-02]
  3. DOD [PC120857, LC130463]
  4. DOD
  5. Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University

向作者/读者索取更多资源

Identification of patients with early stage non-small cell lung cancer (NSCLC) with high risk of recurrence could help identify patients who would receive additional benefit from adjuvant therapy. In this work, we present a computational histomorphometric image classifier using nuclear orientation, texture, shape, and tumor architecture to predict disease recurrence in early stage NSCLC from digitized H&E tissue microarray (TMA) slides. Using a retrospective cohort of early stage NSCLC patients (Cohort #1, n = 70), we constructed a supervised classification model involving the most predictive features associated with disease recurrence. This model was then validated on two independent sets of early stage NSCLC patients, Cohort #2 (n = 119) and Cohort #3 (n = 116). The model yielded an accuracy of 81% for prediction of recurrence in the training Cohort #1, 82% and 75% in the validation Cohorts #2 and #3 respectively. A multivariable Cox proportional hazard model of Cohort #2, incorporating gender and traditional prognostic variables such as nodal status and stage indicated that the computer extracted histomorphometric score was an independent prognostic factor (hazard ratio = 20.81, 95% CI: 6.42-67.52, P < 0.001).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

The contemporary management of cancers of the sinonasal tract in adults

Rajat Thawani, Myung Sun Kim, Asad Arastu, Zizhen Feng, Malinda T. West, Nicholas F. Taflin, Kyaw Zin Thein, Ryan Li, Mathew Geltzeiler, Nancy Lee, Clifton David Fuller, Jennifer R. Grandis, Charalampos S. Floudas, Michael C. Heinrich, Ehab Hanna, Ravi A. Chandra

Summary: This review provides an overview of the incidence, diagnosis, treatment, and recent developments of sinonasal malignancies, including various types and potential malignancies encountered in the sinonasal tract.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Endocrinology & Metabolism

Paraganglioma of the Head and Neck: A Review

Lyndsey Sandow, Rajat Thawani, Myung Sun Kim, Michael C. Heinrich

Summary: This article reviews the epidemiology, presentation, diagnosis, and management of head and neck paragangliomas. The majority of head and neck paragangliomas are benign, but a small percentage can metastasize and significantly impact patient survival. Diagnosis and management methods include biochemical testing, imaging modalities, and surgical intervention. Prognosis of head and neck paragangliomas varies depending on the pathology, location, and aggressiveness of the tumor.

ENDOCRINE PRACTICE (2023)

Article Gastroenterology & Hepatology

Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study

Prathyush Chirra, Anamay Sharma, Kaustav Bera, H. Matthew Cohn, Jacob A. Kurowski, Katelin Amann, Marco-Jose Rivero, Anant Madabhushi, Cheng Lu, Rajmohan Paspulati, Sharon L. Stein, Jeffrey A. Katz, Satish E. Viswanath, Maneesh Dave

Summary: Radiomic features extracted from magnetic resonance enterography are associated with the need for surgery in Crohn's disease patients at risk of complications, and when combined with clinical variables and radiological assessment, they can accurately predict the time to surgery.

INFLAMMATORY BOWEL DISEASES (2023)

Article Oncology

Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer

Rajat Thawani, Neha Agrawal, Nicholas F. Taflin, Adel Kardosh, Emerson Y. Chen

Summary: By assessing the ASCO Net Health Benefit Score (NHBS) and ESMO Magnitude of Clinical Benefit Scale (MCBS), we found mixed results in recent trials testing immune-checkpoint inhibitors in esophago-gastric malignancies. The NHBS and MCBS scores were consistently higher in esophageal cancer trials than gastric cancer trials, as well as in high PD-L1 expression cases compared to low expression cases. Therefore, histology and PD-L1 expression should be taken into consideration when discussing the value of immunotherapy.

ONCOLOGIST (2023)

Article Oncology

Automated analysis of computerized morphological features of cell clusters associated with malignancy on bile duct brushing whole slide images

Shayan Monabbati, Patrick Leo, Kaustav Bera, Claire W. Michael, Behtash G. Nezami, Aparna Harbhajanka, Anant Madabhushi

Summary: This study used computational image analysis to predict the presence of pancreatic and biliary tract adenocarcinoma on digitized brush cytology specimens. By extracting nuclear morphological and texture features and training machine learning classifiers, the researchers successfully improved the sensitivity and specificity of diagnosis.

CANCER MEDICINE (2023)

Article Computer Science, Artificial Intelligence

Multi-site cross-organ calibrated deep learning (MuSClD): Automated diagnosis of non-melanoma skin cancer

Yufei Zhou, Can Koyuncu, Cheng Lu, Rainer Grobholz, Ian Katz, Anant Madabhushi, Andrew Janowczyk

Summary: Deep learning performs well in computational pathology tasks but struggles with domain shift on whole slide images generated at external test sites. To address this, researchers propose using off-target organs from the test site for calibration, effectively mitigating the domain shift and improving the robustness of the model for skin cancer classification.

MEDICAL IMAGE ANALYSIS (2023)

Article Oncology

Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment

Robert Serafin, Can Koyuncu, Weisi Xie, Hongyi Huang, Adam K. Glaser, Nicholas P. Reder, Andrew Janowczyk, Lawrence D. True, Anant Madabhushi, Jonathan T. C. Liu

Summary: Previous studies have shown that computational analysis of 2D histology images can improve prognostication of prostate cancer outcomes. This study expands on previous work by exploring the prognostic value of 3D shape-based nuclear features in prostate cancer. The results suggest that these features are associated with cancer aggressiveness and could be valuable for decision-support tools.

JOURNAL OF PATHOLOGY (2023)

Article Oncology

Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer

Cristian Barrera, German Corredor, Vidya Sankar Viswanathan, Ruiwen Ding, Paula Toro, Pingfu Fu, Christina Buzzy, Cheng Lu, Priya Velu, Philipp Zens, Sabina Berezowska, Merzu Belete, David Balli, Han Chang, Vipul Baxi, Konstantinos Syrigos, David L. Rimm, Vamsidhar Velcheti, Kurt Schalper, Eduardo Romero, Anant Madabhushi

Summary: The tumor immune composition has an impact on prognosis and treatment sensitivity in lung cancer. Effective adaptive immune responses are associated with better clinical outcomes after immune checkpoint blockers, while immunotherapy resistance can occur due to T-cell exhaustion, immunosuppressive signals, and regulatory cells. This study investigates a new computational pathology approach called PhenoTIL, which uses machine learning to analyze the spatial interactions and functional features of immune cell niches associated with tumor rejection and patient outcomes in non-small cell lung cancer (NSCLC). The study demonstrates the potential of PhenoTIL as a valuable biomarker for treatment-specific outcomes in NSCLC.

NPJ PRECISION ONCOLOGY (2023)

Article Oncology

CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma

Bolin Song, Kailin Yang, Vidya Sankar Viswanathan, Xiangxue Wang, Jonathan Lee, Sarah Stock, Pingfu Fu, Cheng Lu, Shlomo Koyfman, James S. Lewis, Anant Madabhushi

Summary: This study aimed to develop and validate a prognostic and predictive radiomic image signature (pRiS) using CT scans to inform survival and chemotherapy benefit in HPV-associated OPSCC. The results showed that pRiS was able to predict patient survival and determine whether chemotherapy provided additional benefit.

NPJ PRECISION ONCOLOGY (2023)

Review Oncology

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

Jeppe Thagaard, Glenn Broeckx, David B. Page, Chowdhury Arif Jahangir, Sara Verbandt, Zuzana Kos, Rajarsi Gupta, Reena Khiroya, Khalid Abduljabbar, Gabriela Acosta Haab, Balazs Acs, Guray Akturk, Jonas S. Almeida, Isabel Alvarado-Cabrero, Mohamed Amgad, Farid Azmoudeh-Ardalan, Sunil Badve, Nurkhairul Bariyah Baharun, Eva Balslev, Enrique R. Bellolio, Vydehi Bheemaraju, Kim R. M. Blenman, Luciana Botinelly Mendonca Fujimoto, Najat Bouchmaa, Octavio Burgues, Alexandros Chardas, Maggie U. Cheang, Francesco Ciompi, Lee A. D. Cooper, An Coosemans, German Corredor, Anders B. Dahl, Flavio Luis Dantas Portela, Frederik Deman, Sandra Demaria, Johan Dore Hansen, Sarah N. Dudgeon, Thomas Ebstrup, Mahmoud Elghazawy, Claudio Fernandez-Martin, Stephen B. Fox, William M. Gallagher, Jennifer M. Giltnane, Sacha Gnjatic, Paula Gonzalez-Ericsson, Anita Grigoriadis, Niels Halama, Matthew G. Hanna, Aparna Harbhajanka, Steven N. Hart, Johan Hartman, Soren Hauberg, Stephen Hewitt, Akira Hida, Hugo M. Horlings, Zaheed Husain, Evangelos Hytopoulos, Sheeba Irshad, Emiel A. M. Janssen, Mohamed Kahila, Tatsuki R. Kataoka, Kosuke Kawaguchi, Durga Kharidehal, Andrey Khramtsov, Umay Kiraz, Pawan Kirtani, Liudmila L. Kodach, Konstanty Korski, Aniko Kovacs, Anne-Vibeke Laenkholm, Corinna Lang-Schwarz, Denis Larsimont, Jochen K. Lennerz, Marvin Lerousseau, Xiaoxian Li, Amy Ly, Anant Madabhushi, Sai K. Maley, Vidya Manur Narasimhamurthy, Douglas K. Marks, Elizabeth S. McDonald, Ravi Mehrotra, Stefan Michiels, Fayyaz ul Amir Afsar Minhas, Shachi Mittal, David A. Moore, Shamim Mushtaq, Hussain Nighat, Thomas Papathomas, Frederique Penault-Llorca, Rashindrie D. Perera, Christopher J. Pinard, Juan Carlos Pinto-Cardenas, Giancarlo Pruneri, Lajos Pusztai, Arman Rahman, Nasir Mahmood Rajpoot, Bernardo Leon Rapoport, Tilman T. Rau, Jorge S. Reis-Filho, Joana M. Ribeiro, David Rimm, Anne Roslind, Anne Vincent-Salomon, Manuel Salto-Tellez, Joel Saltz, Shahin Sayed, Ely Scott, Kalliopi P. Siziopikou, Christos Sotiriou, Albrecht Stenzinger, Maher A. Sughayer, Daniel Sur, Susan Fineberg, Fraser Symmans, Sunao Tanaka, Timothy Taxter, Sabine Tejpar, Jonas Teuwen, E. Aubrey Thompson, Trine Tramm, William T. Tran, Jeroen van Der Laak, Paul J. van Diest, Gregory E. Verghese, Giuseppe Viale, Michael Vieth, Noorul Wahab, Thomas Walter, Yannick Waumans, Hannah Y. Wen, Wentao Yang, Yinyin Yuan, Reena Md Zin, Sylvia Adams, John Bartlett, Sibylle Loibl, Carsten Denkert, Peter Savas, Sherene Loi, Roberto Salgado, Elisabeth Specht Stovgaard

Summary: The clinical significance of tumor-immune interaction in breast cancer has been established. Tumor-infiltrating lymphocytes (TILs) have emerged as predictive and prognostic biomarkers for patients with triple-negative and HER2-positive breast cancer. The use of machine learning (ML) to automatically evaluate TILs has shown promising results. However, there are challenges in implementing this in trial and routine clinical management, including technical slide issues, ML and image analysis aspects, data challenges, and validation issues.

JOURNAL OF PATHOLOGY (2023)

Review Oncology

Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

David B. Page, Glenn Broeckx, Chowdhury Arif Jahangir, Chowdhury Jahangir, Sara Verbandt, Rajarsi R. Gupta, Jeppe Thagaard, Reena Khiroya, Zuzana Kos, Khalid Abduljabbar, Gabriela Acosta Haab, Balazs Acs, Jonas S. Almeida, Isabel Alvarado-Cabrero, Farid Azmoudeh-Ardalan, Sunil Badve, Nurkhairul Bariyah Baharun, Enrique R. Bellolio, Vydehi Bheemaraju, Kim R. M. Blenman, Luciana Botinelly Mendonca Fujimoto, Octavio Burgues, Maggie Chon U. Cheang, Francesco Ciompi, Lee A. D. Cooper, An Coosemans, German Corredor, Flavio Luis Dantas Portela, Frederik Deman, Sandra Demaria, Sarah N. Dudgeon, Mahmoud Elghazawy, Scott Ely, Claudio Fernandez-Martin, Susan Fineberg, Stephen B. Fox, William M. Gallagher, Jennifer M. Giltnane, Sacha Gnjatic, Paula Gonzalez-Ericsson, Anita Grigoriadis, Niels Halama, Matthew G. Hanna, Aparna Harbhajanka, Alexandros Hardas, Steven N. Hart, Johan Hartman, Stephen Hewitt, Akira Hida, Hugo M. Horlings, Zaheed Husain, Evangelos Hytopoulos, Sheeba Irshad, Emiel A. M. Janssen, Mohamed Kahila, Tatsuki R. Kataoka, Kosuke Kawaguchi, Durga Kharidehal, Andrey Khramtsov, Umay Kiraz, Pawan Kirtani, Liudmila L. Kodach, Konstanty Korski, Aniko Kovacs, Anne-Vibeke Laenkholm, Corinna Lang-Schwarz, Denis Larsimont, Jochen K. Lennerz, Marvin Lerousseau, Xiaoxian Li, Amy Ly, Anant Madabhushi, Sai K. Maley, Vidya Manur Narasimhamurthy, Douglas K. Marks, Elizabeth S. McDonald, Ravi Mehrotra, Stefan Michiels, Fayyaz ul Amir Afsar Minhas, Shachi Mittal, David A. Moore, Shamim Mushtaq, Hussain Nighat, Thomas Papathomas, Frederique Penault-Llorca, Rashindrie D. Perera, Christopher J. Pinard, Juan Carlos Pinto-Cardenas, Giancarlo Pruneri, Lajos Pusztai, Arman Rahman, Nasir Mahmood Rajpoot, Bernardo Leon Rapoport, Tilman T. Rau, Jorge S. Reis-Filho, Joana M. Ribeiro, David Rimm, Anne-Vincent Salomon, Manuel Salto-Tellez, Joel Saltz, Shahin Sayed, Kalliopi P. Siziopikou, Christos Sotiriou, Albrecht Stenzinger, Maher A. Sughayer, Daniel Sur, Fraser Symmans, Sunao Tanaka, Timothy Taxter, Sabine Tejpar, Jonas Teuwen, E. Aubrey Thompson, Trine Tramm, William T. Tran, Jeroen van Der Laak, Paul J. van Diest, Gregory E. Verghese, Giuseppe Viale, Michael Vieth, Noorul Wahab, Thomas Walter, Yannick Waumans, Hannah Y. Wen, Wentao Yang, Yinyin Yuan, Sylvia Adams, John Mark Seaverns Bartlett, Sibylle Loibl, Carsten Denkert, Peter Savas, Sherene Loi, Roberto Salgado, Elisabeth Specht Stovgaard, Guray Akturk, Najat Bouchmaa

Summary: Modern histologic imaging platforms combined with machine learning methods offer new opportunities for studying the spatial distribution of immune cells in the tumor microenvironment. However, there is currently no standardized method for describing or analyzing spatial immune cell data, and most previous spatial analyses have been simplistic. In this review, two approaches (raster versus vector-based) for reporting and analyzing spatial data are outlined, along with a summary of reported spatial immune cell metrics and their prognostic associations in various cancers. Two well-described clinical biomarkers, the breast cancer stromal tumor infiltrating lymphocytes score and the colon cancer Immunoscore, are also discussed, along with potential research opportunities to improve the clinical utility of these spatial biomarkers.

JOURNAL OF PATHOLOGY (2023)

Article Oncology

Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings

Abhishek Midya, Amogh Hiremath, Jacob Huber, Vidya Sankar Viswanathan, Danly Omil-Lima, Amr Mahran, Leonardo K. Bittencourt, Sree Harsha Tirumani, Lee Ponsky, Rakesh Shiradkar, Anant Madabhushi

Summary: The objective of this study was to quantify radiomic changes in prostate cancer progression on serial MRI among patients on active surveillance and evaluate their association with pathologic progression on biopsy. The study found that delta radiomics were more strongly associated with upgrade events compared to other clinical variables, and the combination of delta radiomics with baseline clinical variables showed the strongest association with biopsy upgrade prediction.

FRONTIERS IN ONCOLOGY (2023)

Article Oncology

Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer

Mohammadhadi Khorrami, Vidya Sakar Viswanathan, Priyanka Reddy, Nathaniel Braman, Siddharth Kunte, Amit Gupta, Jame Abraham, Alberto J. Montero, Anant Madabhushi

Summary: Imaging texture biomarkers before and after CDK4/6i therapy can predict early response and overall survival in MBC patients with liver metastases. Radiomic features can predict a lack of response earlier than standard anatomic/RECIST 1.1 assessment, highlighting the need for further study and clinical validation.

NPJ BREAST CANCER (2023)

Article Pathology

Identifying primary tumor site of origin for liver metastases via a combination of handcrafted and deep learning features

Chuheng Chen, Cheng Lu, Vidya Viswanathan, Brandon Maveal, Bhunesh Maheshwari, Joseph Willis, Anant Madabhushi

Summary: This study uses computer-extracted histomorphometric features to identify the primary site of origin for liver metastases. It found that features related to nuclear and peri-nuclear shape were the most important in classifying different metastatic tumors. Additionally, attention maps generated by a deep learning network can provide a composite feature similarity heat map between primary tumors and their associated metastases.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2023)

Article Computer Science, Interdisciplinary Applications

Automatic myeloblast segmentation in acute myeloid leukemia images based on adversarial feature learning

Zelin Zhang, Sara Arabyarmohammadi, Patrick Leo, Howard Meyerson, Leland Metheny, Jun Xu, Anant Madabhushi

Summary: This article introduces a segmentation model based on conditional generative adversarial network for efficient segmentation of myeloblasts from slides of AML patients. Through validation experiments, it is confirmed that this method has better segmentation performance than other deep learning models, and prognostic models for predicting the risk of recurrence in AML patients have been constructed using the segmentation results.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2024)

暂无数据